Recurrent C.difficile;antibiotic MIC's, Genomics & biomarkers.

• Research type

  Research Study

• Full title

  Treatment failure, severity and recurrence of Clostridioides difficile infection; utility of antimicrobial susceptibility testing, biomarker and genomic tools to predict infection

• IRAS ID

  326646

• Contact name

  Rushana Hussain

• Contact email

  rushana.hussain@boltonft.nhs.uk

• Sponsor organisation

  Royal Bolton Hospital

• Duration of Study in the UK

  1 years, 6 months, 1 days

• Research summary

  The study aims to establish if there is a relation to antibiotic sensitivity or genetic components in patients that have recurrent Clostridium difficile infection. It will also investigate if the biomarker calprotectin can be used to predict recurrent infection.

• REC name

  Yorkshire & The Humber - Leeds East Research Ethics Committee

• REC reference

  24/YH/0061

• Date of REC Opinion

  24 Apr 2024

• REC opinion

  Further Information Favourable Opinion